MX2010000856A - Composicion farmaceutica que contiene un antagonista del canal de calcio de tipo dihidropiridina y metodo para la preparacion de la misma. - Google Patents

Composicion farmaceutica que contiene un antagonista del canal de calcio de tipo dihidropiridina y metodo para la preparacion de la misma.

Info

Publication number
MX2010000856A
MX2010000856A MX2010000856A MX2010000856A MX2010000856A MX 2010000856 A MX2010000856 A MX 2010000856A MX 2010000856 A MX2010000856 A MX 2010000856A MX 2010000856 A MX2010000856 A MX 2010000856A MX 2010000856 A MX2010000856 A MX 2010000856A
Authority
MX
Mexico
Prior art keywords
preparation
calcium channel
channel antagonist
pharmaceutical composition
composition containing
Prior art date
Application number
MX2010000856A
Other languages
English (en)
Spanish (es)
Inventor
Evangelos Karavas
Efthimios Koutris
Ioanna Koutri
Eleni Sthathaki
Original Assignee
Pharmathen Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39223083&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2010000856(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pharmathen Sa filed Critical Pharmathen Sa
Publication of MX2010000856A publication Critical patent/MX2010000856A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Vascular Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Hydrogenated Pyridines (AREA)
MX2010000856A 2007-07-23 2007-07-23 Composicion farmaceutica que contiene un antagonista del canal de calcio de tipo dihidropiridina y metodo para la preparacion de la misma. MX2010000856A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2007/006517 WO2009012791A1 (en) 2007-07-23 2007-07-23 Pharmaceutical composition containing dihydropyridine calcium channel antagonist and method for the preparation thereof

Publications (1)

Publication Number Publication Date
MX2010000856A true MX2010000856A (es) 2010-04-30

Family

ID=39223083

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2010000856A MX2010000856A (es) 2007-07-23 2007-07-23 Composicion farmaceutica que contiene un antagonista del canal de calcio de tipo dihidropiridina y metodo para la preparacion de la misma.
MX2010000801A MX2010000801A (es) 2007-07-23 2008-07-23 Composicion farmaceutica mejorada que contiene antagonista de canal de calcio de dihidropiridina y metodo para su preparacion.

Family Applications After (1)

Application Number Title Priority Date Filing Date
MX2010000801A MX2010000801A (es) 2007-07-23 2008-07-23 Composicion farmaceutica mejorada que contiene antagonista de canal de calcio de dihidropiridina y metodo para su preparacion.

Country Status (20)

Country Link
EP (2) EP2180883B1 (enExample)
JP (2) JP5769963B2 (enExample)
KR (2) KR101632079B1 (enExample)
CN (3) CN101784260A (enExample)
AU (2) AU2007356942B2 (enExample)
BR (2) BRPI0721883A2 (enExample)
CA (2) CA2691752C (enExample)
CO (1) CO6290639A2 (enExample)
CR (1) CR11285A (enExample)
EA (2) EA021645B1 (enExample)
EC (1) ECSP109984A (enExample)
ES (2) ES2622495T3 (enExample)
MA (1) MA31684B1 (enExample)
MX (2) MX2010000856A (enExample)
MY (1) MY153857A (enExample)
NZ (2) NZ582648A (enExample)
TN (2) TN2010000011A1 (enExample)
UA (2) UA97161C2 (enExample)
WO (2) WO2009012791A1 (enExample)
ZA (2) ZA201000586B (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008063888A2 (en) 2006-11-22 2008-05-29 Plexxikon, Inc. Compounds modulating c-fms and/or c-kit activity and uses therefor
AU2008276063B2 (en) 2007-07-17 2013-11-28 Plexxikon Inc. Compounds and methods for kinase modulation, and indications therefor
KR101632079B1 (ko) * 2007-07-23 2016-06-20 파마덴 에스.에이. 디히드로피리딘 칼슘 채널 길항제를 함유하는 약제학적 조성물 및 그것의 제조방법
JP5511942B2 (ja) * 2009-04-03 2014-06-04 エフ ホフマン−ラ ロッシュ アクチェン ゲゼルシャフト 組成物及びその使用
US8329724B2 (en) 2009-08-03 2012-12-11 Hoffmann-La Roche Inc. Process for the manufacture of pharmaceutically active compounds
EP2496086B1 (en) 2009-11-06 2017-05-31 Plexxikon Inc. Compounds and methods for kinase modulation, and indications therefor
SI2672967T1 (sl) 2011-02-07 2018-12-31 Plexxikon Inc. Spojine in postopki za kinazno modulacijo in indikacije zanjo
AR085279A1 (es) 2011-02-21 2013-09-18 Plexxikon Inc Formas solidas de {3-[5-(4-cloro-fenil)-1h-pirrolo[2,3-b]piridina-3-carbonil]-2,4-difluor-fenil}-amida del acido propano-1-sulfonico
US9150570B2 (en) 2012-05-31 2015-10-06 Plexxikon Inc. Synthesis of heterocyclic compounds
PL2919903T3 (pl) 2012-11-14 2020-12-14 W.R. Grace & Co. - Conn. Kompozycje zawierające materiał biologicznie aktywny i nieuporządkowany tlenek nieorganiczny
GR1008554B (el) * 2014-06-12 2015-09-03 ΦΑΡΜΑΤΕΝ ΑΝΩΝΥΜΟΣ ΒΙΟΜΗΧΑΝΙΚΗ ΚΑΙ ΕΜΠΟΡΙΚΗ ΕΤΑΙΡΕΙΑ ΦΑΡΜΑΚΕΥΤΙΚΩΝ ΙΑΤΡΙΚΩΝ ΚΑΙ ΚΑΛΛΥΝΤΙΚΩΝ ΠΡΟΪΟΝΤΩΝ με δ.τ. ΦΑΡΜΑΤΕΝ, Φαρμακευτικο σκευασμα περιεχον εναν αντιμυκητιασικο παραγοντα τριaζολης και μεθοδος για την παρασκευη αυτου
CN104069500A (zh) * 2014-06-20 2014-10-01 湖南天地恒一制药有限公司 一种包含乐卡地平的药物组合物
CN105168165B (zh) * 2015-08-28 2018-06-26 江苏福邦药业有限公司 一种盐酸乐卡地平片及其制备方法
WO2018004379A1 (ru) * 2016-07-01 2018-01-04 Общество С Ограниченной Ответственностью "Гиостин" Средство в виде капсулы для лечения заболеваний суставов
BR112020019425A2 (pt) 2018-03-22 2020-12-29 Komipharm International Australia Pty Ltd Composição farmacêutica compreendendo meta-arsenito e método de fabricação
CN114533686B (zh) * 2022-02-15 2023-10-20 湖南普道医药技术有限公司 一种二氢吡啶类药物的口服固体制剂及其制备方法
KR20240040407A (ko) * 2022-09-21 2024-03-28 주식회사 종근당 사쿠비트릴ㆍ발사르탄 칼슘염을 포함하는 약제학적 조성물

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3720757A1 (de) * 1987-06-24 1989-01-05 Bayer Ag Dhp-manteltablette
US5209933A (en) * 1990-01-10 1993-05-11 Syntex (U.S.A.) Inc. Long acting calcium channel blocker composition
GB9025251D0 (en) * 1990-11-20 1991-01-02 Solomon Montague C Nifedipine dosage forms
BR9903490A (pt) * 1998-12-15 2000-09-26 Oscar Gold Processo para a preparação de composições farmacêuticas de liberação programada contendo nimodipine, que permitem a liberação gradual e a manuntenção da ação terapeutica
DE19944803A1 (de) * 1999-09-20 2001-03-29 Bayer Ag Kombination von Dihydropyridinverbindungen und HMG-CoA-Reduktase-Inhibitoren und ihre Verwendung in Arzneimitteln
US20040185097A1 (en) * 2003-01-31 2004-09-23 Glenmark Pharmaceuticals Ltd. Controlled release modifying complex and pharmaceutical compositions thereof
ZA200605290B (en) * 2003-12-01 2007-10-31 Lifecycle Pharma As Pharmaceutical compositions comprising lercanidipine
AU2004294674B2 (en) * 2003-12-01 2009-02-26 Recordati Ireland Limited Pharmaceutical compositions comprising lercanidipine
MX2009002235A (es) * 2006-08-30 2009-03-13 Jagotec Ag Formulaciones de dosis oral, solidas, de liberacion controlada que comprenden nisoldipina.
EP2101771A2 (en) * 2006-12-06 2009-09-23 Torrent Pharmaceuticals Ltd Stable lercanidipine formulation
KR101632079B1 (ko) * 2007-07-23 2016-06-20 파마덴 에스.에이. 디히드로피리딘 칼슘 채널 길항제를 함유하는 약제학적 조성물 및 그것의 제조방법

Also Published As

Publication number Publication date
EP2170295A1 (en) 2010-04-07
UA99136C2 (ru) 2012-07-25
EA021645B1 (ru) 2015-08-31
AU2008280106B9 (en) 2014-08-07
CA2691752A1 (en) 2009-01-29
ZA201000586B (en) 2011-03-30
AU2008280106A1 (en) 2009-01-29
ES2537063T3 (es) 2015-06-02
CO6290639A2 (es) 2011-06-20
KR101512404B1 (ko) 2015-04-21
NZ582648A (en) 2012-06-29
EP2170295B1 (en) 2015-04-22
MX2010000801A (es) 2010-07-05
CN103976968A (zh) 2014-08-13
NZ582690A (en) 2011-12-22
EP2180883B1 (en) 2017-01-11
ZA201001176B (en) 2010-11-24
UA97161C2 (ru) 2012-01-10
BRPI0814666A2 (pt) 2017-05-09
KR20100045456A (ko) 2010-05-03
CR11285A (es) 2010-04-27
ECSP109984A (es) 2010-04-30
BRPI0721883A2 (pt) 2014-02-18
ES2622495T3 (es) 2017-07-06
WO2009012791A1 (en) 2009-01-29
AU2007356942A1 (en) 2009-01-29
JP5769963B2 (ja) 2015-08-26
EA201000220A1 (ru) 2010-08-30
CA2691752C (en) 2016-01-26
CA2693233A1 (en) 2009-01-29
EA019614B1 (ru) 2014-05-30
MY153857A (en) 2015-03-31
CN101801347A (zh) 2010-08-11
JP2010534220A (ja) 2010-11-04
AU2008280106A2 (en) 2010-02-25
TN2010000011A1 (en) 2011-09-26
KR101632079B1 (ko) 2016-06-20
JP2010534211A (ja) 2010-11-04
EP2180883A1 (en) 2010-05-05
AU2007356942B2 (en) 2011-12-15
CN101784260A (zh) 2010-07-21
MA31684B1 (fr) 2010-09-01
AU2008280106B2 (en) 2014-03-20
WO2009013306A1 (en) 2009-01-29
KR20100047848A (ko) 2010-05-10
EA201070160A1 (ru) 2010-06-30
TN2010000022A1 (en) 2011-09-26

Similar Documents

Publication Publication Date Title
MX2010000856A (es) Composicion farmaceutica que contiene un antagonista del canal de calcio de tipo dihidropiridina y metodo para la preparacion de la misma.
CR11137A (es) Valvulas prosteticas de corazon
JO2973B1 (en) Fumarate salt for (alpha-beta-R) -6-bromo-alpha-[2- (methylamino) ethyl-2-methoxy-alpha-1-naphthalenyl-beta-phenyl-3-quinoline ethanol
WO2014016754A3 (en) Pharmaceutical compositions of proton pump inhibitor
ZA201003380B (en) Improved pharmaceutical composition containing a pyrrolidone anticonvulsant agent and methhod for the preparation thereof
WO2008001201A3 (en) Pharmaceutical compositions of clopidogrel
WO2010070677A3 (en) A process for the preparation of prasugrel and its pharmaceutically acceptable salts thereof
NZ591204A (en) Pharmaceutical compositions and methods for stabilizing the same
PH12017501397A1 (en) (2s, 4r)-5-(5`-chloro-2`-fluorobiphenyl-4-yl)-4-(ethoxyoxalylamino)-2-hydroxymethyl-2-methylpentanoic acid as neprilysin inhibitor
WO2010044097A3 (en) Novel dosage form of paliperidone and process for preparing the same
WO2007110765A3 (en) Processes for the preparation of octreotide
GR1008821B (el) Φαρμακευτικο σκευασμα που περιλαμβανει υδροχλωρικη ιβαμπραδινη και μεθοδος παρασκευης αυτου
MX2007010400A (es) Nuevas sales de derivados de hexahidrofenantridina sustituida con 6-heterociclilo.
GR20070100405A (el) Βελτιωμενες φαρμακοτεχνικες μορφες που περιεχουν αναστολεις της ακετυλοχοληνεστερασης και μεθοδοι παρασκευης αυτων
EA201190282A1 (ru) Фармацевтическая композиция, содержащая тамсулозин
MY150480A (en) Pharmaceutical composition containing dihydropyridine calcium channel antagonist and method for the preparation thereof
PL401632A1 (pl) Kompozycja farmaceutyczna zawierająca inhibitor ACE i bloker kanałów wapniowych, sposób jej wytwarzania i jednostka dawkowania zawierająca tę kompozycję
CY1108846T1 (el) Βελτιωμενη φαρμακευτικη συνθεση που περιεχει αναστολεα ace και μεθοδος για την παρασκευη της
WO2011086577A3 (en) Pharmaceutical composition of moxifloxacin and its pharmaceutically acceptable salts
WO2010061219A3 (en) Polymorphs
WO2010046912A3 (en) Thiophene containing analogues of fluconazole as antifungal agents and process for their preparation
WO2007052167A3 (en) Stable composition for a pharmaceutical formulation containing olanzapine
CO6260055A2 (es) Composicion farmaceutica que contiene un antagonista del canal de calcio de tipo dihidropiridina y metodo para la preparacion de la misma
WO2014141298A3 (en) Stable pharmaceutical composition of fingolimod
GR1007629B (el) Φαρμακευτικο σκευασμα ελεγχομενης αποδεσμευσης ενος μη εργολινικου αγωνιστη της ντοπαμινης

Legal Events

Date Code Title Description
FG Grant or registration